ICER’s Unsupported Price Increase Report: Unfit for Policymaking
自 2019 年以来,临床与经济审查研究所(ICER)每年都会发布一份《Unsupported Price Increase (UPI) Report ,介绍其 "在没有任何新临床证据的情况下对大幅涨价药物的评估",以指导处方药的政策制定。美国立法者对 UPI 方法表现出了兴趣,将其作为一种潜在的工具来...Continued
自 2019 年以来,临床与经济审查研究所(ICER)每年都会发布一份《Unsupported Price Increase (UPI) Report ,介绍其 "在没有任何新临床证据的情况下对大幅涨价药物的评估",以指导处方药的政策制定。美国立法者对 UPI 方法表现出了兴趣,将其作为一种潜在的工具来...Continued
In a world of rising healthcare costs, the greatest nightmare for payers is reimbursing drug interventions that do not meaningfully benefit their covered lives. Rare disease therapies, often viewed as attractive areas for pharmaceutical & biotech manufacturers, represent some of the most expensive interventions available today given inherently limited competition. Yet, as more manufacturers enter … Continued
This is Part 1 of the ‘Succeeding in Value Communication’ series, a set of articles that examine the key success factors in creating customer engagement tools that successfully communicate the clinical and economic benefits of pharmaceuticals, devices and diagnostics. These recommendations have been drawn from the experiences of the BaseCase Consulting Team. Create a key … Continued
Drawn from the experiences of the BaseCase Consulting Team, this is the introduction to ‘Succeeding in Value Communication’. This series of blog articles examines the key success factors in creating customer engagement tools that effectively communicate the clinical value and economic benefits of pharmaceuticals, medical devices, and diagnostic tests. How do you communicate the value … Continued
This is Part 2 of the ‘Succeeding in Value Communication’ series, a set of articles that examine the key success factors in creating customer engagement tools that successfully communicate the clinical and economic benefits of pharmaceuticals, devices and diagnostics. These recommendations have been drawn from the experiences of the BaseCase Consulting Team. Make your value … Continued
This is Part 3 of the ‘Succeeding in Value Communication’ series, a set of articles that examine the key success factors in creating customer engagement tools that successfully communicate the clinical and economic benefits of pharmaceuticals, devices and diagnostics. These recommendations have been drawn from the experiences of the BaseCase Consulting Team. A single value … Continued
This is Part 4 of the ‘Succeeding in Value Communication’ series, a set of articles that examine the key success factors in creating customer engagement tools that successfully communicate the clinical and economic benefits of pharmaceuticals, devices and diagnostics. These recommendations have been drawn from the experiences of the BaseCase Consulting Team. Never stop testing … Continued